{
    "2020-06-22": [
        [
            {
                "time": "",
                "original_text": "【民生医药|周报】持续推荐特色原料药及医药服务，关注全国集采后的替代空间",
                "features": {
                    "keywords": [
                        "特色原料药",
                        "医药服务",
                        "全国集采",
                        "替代空间"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药特色原料药行业系列研究：从关联审评数据 看API行业生态演绎",
                "features": {
                    "keywords": [
                        "特色原料药",
                        "关联审评",
                        "API行业",
                        "生态演绎"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "民生证券研究周观点",
                "features": {
                    "keywords": [
                        "民生证券",
                        "研究",
                        "周观点"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英(002821)：技术驱动的CDMO领导者 把握机遇 快速腾飞",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "CDMO",
                        "技术驱动",
                        "快速腾飞"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本48亿参与四家公司定增 携资金及业务增量入局加深合作",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "定增",
                        "资金",
                        "业务增量",
                        "加深合作"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "投资"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}